["Medication, Administered": "Unfractionated Heparin"]
Performance/Reporting Period
2021
Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent heparin formulations that could reasonably be used to treat venous thromboembolism as a continuous infusion.
Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. The intent of this data element is to identify patients who receive unfractionated heparin as an intravenous infusion.
Inclusion Criteria: Includes only relevant concepts associated with injectable products that could reasonably be used for continuous infusion of heparin and achieve therapeutic levels.
Exclusion Criteria: Excludes concentrations < 250 UNT/ML (except those representing premixed heparin infusion bags, per inclusion criteria).
Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. The intent of this data element is to identify patients who receive unfractionated heparin as an intravenous infusion.
Inclusion Criteria: Includes only relevant concepts associated with injectable products that could reasonably be used for continuous infusion of heparin and achieve therapeutic levels.
Exclusion Criteria: Excludes concentrations < 250 UNT/ML (except those representing premixed heparin infusion bags, per inclusion criteria).
Constrained to codes in the Medication, Administered: Unfractionated Heparin value set (2.16.840.1.113883.3.117.1.7.1.218)
QDM Datatype and Definition
"Medication, Administered"
Data elements that meet criteria using this datatype should document that the medication indicated by the QDM category and its corresponding value set was actually administered to the patient.
Timing:
- relevant dateTime references the time the medication is administered if it was given or taken at a single point in time.
- relevantPeriod references a start and stop time for medication administration if the administration event occurred over a time interval (e.g., an intravenous infusion). The relevantPeriod addresses:
- startTime - when a single medication administration event starts (e.g., the initiation of an intravenous infusion).
- stopTime - when a single medication administration event ends (e.g., the end time of the intravenous infusion).
- author dateTime references the time the action was recorded.
- Refer to the eCQM expression to determine allowable timings to meet measure criterion.
Notes:
- Measure developers should address multiple administrations over a period of time using CQL logic.
- negation rationale indicates a one-time documentation of a reason an activity is not performed. Negation of QDM datatype-related actions for a reason always use the author dateTime attribute to reference timing and must not use relevantPeriod.
Refer to Special Cases in Appendix A (Section 5.7) for scenarios to consider in calculating cumulative medication duration.
QDM Attributes
route
Refers to the path by which the medication or substance should be taken into the body system, such as intradermally, intrathecally, intramuscularly, intranasally, intravenously, orally, rectally, subcutaneously, sublingually, topically, or vaginally.
Last Updated: Jul 08, 2021